These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 7499857
21. TCR alpha beta+ anti-tumor cytolytic T lymphocytes express NKR-P1 whilethe anti-tumor activity of TCR gamma delta+ T lymphocytes is not correlated to NKR-P1 expression. Yrlid U, Petersson E, Dohlsten M, Hedlund G. Cell Immunol; 1996 Nov 01; 173(2):287-94. PubMed ID: 8912889 [Abstract] [Full Text] [Related]
22. Different roles of alpha beta and gamma delta T cells in immunity against an intracellular bacterial pathogen. Mombaerts P, Arnoldi J, Russ F, Tonegawa S, Kaufmann SH. Nature; 1993 Sep 02; 365(6441):53-6. PubMed ID: 8361537 [Abstract] [Full Text] [Related]
23. CD28 expression is not essential for positive and negative selection of thymocytes or peripheral T cell tolerance. Walunas TL, Sperling AI, Khattri R, Thompson CB, Bluestone JA. J Immunol; 1996 Feb 01; 156(3):1006-13. PubMed ID: 8557973 [Abstract] [Full Text] [Related]
24. Immune responsiveness to a murine mammary carcinoma modified to express B7-1, interleukin-12, or GM-CSF. Aruga E, Aruga A, Arca MJ, Lee WM, Yang NS, Smith JW, Chang AE. Cancer Gene Ther; 1997 Feb 01; 4(3):157-66. PubMed ID: 9171934 [Abstract] [Full Text] [Related]
25. Gamma delta TCR+ hybridomas derived from mice preimmunized via the portal vein adoptively transfer increased skin allograft survival in vivo. Gorczynski RM, Cohen Z, Leung Y, Chen Z. J Immunol; 1996 Jul 15; 157(2):574-81. PubMed ID: 8752904 [Abstract] [Full Text] [Related]
26. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells. Bian Y, Hiraoka S, Tomura M, Zhou XY, Yashiro-Ohtani Y, Mori Y, Shimizu J, Ono S, Dunussi-Joannopoulos K, Wolf S, Fujiwara H. Int Immunol; 2005 Jan 15; 17(1):73-83. PubMed ID: 15569772 [Abstract] [Full Text] [Related]
27. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta. Flament C, Benmerah A, Bonneville M, Triebel F, Mami-Chouaib F. J Immunol; 1994 Oct 01; 153(7):2890-904. PubMed ID: 8089476 [Abstract] [Full Text] [Related]
28. Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA-4 costimulatory molecules. Yang G, Hellström KE, Hellström I, Chen L. J Immunol; 1995 Mar 15; 154(6):2794-800. PubMed ID: 7533183 [Abstract] [Full Text] [Related]
29. B7 expression on thymic medullary epithelium correlates with epithelium-mediated deletion of V beta 5+ thymocytes. Degermann S, Surh CD, Glimcher LH, Sprent J, Lo D. J Immunol; 1994 Apr 01; 152(7):3254-63. PubMed ID: 7511640 [Abstract] [Full Text] [Related]
31. In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity. Todo T, Martuza RL, Dallman MJ, Rabkin SD. Cancer Res; 2001 Jan 01; 61(1):153-61. PubMed ID: 11196154 [Abstract] [Full Text] [Related]
32. Influence of gene-modified (IL-7, IL-4, and B7) tumor cell vaccines on tumor antigen presentation. Cayeux S, Richter G, Noffz G, Dörken B, Blankenstein T. J Immunol; 1997 Mar 15; 158(6):2834-41. PubMed ID: 9058819 [Abstract] [Full Text] [Related]
33. Gamma delta T cells function in cell-mediated immunity to acute blood-stage Plasmodium chabaudi adami malaria. van der Heyde HC, Elloso MM, Chang WL, Kaplan M, Manning DD, Weidanz WP. J Immunol; 1995 Apr 15; 154(8):3985-90. PubMed ID: 7706737 [Abstract] [Full Text] [Related]
34. Loss of either CD4+ or CD8+ T cells does not affect the magnitude of protective immunity to an intracellular pathogen, Francisella tularensis strain LVS. Yee D, Rhinehart-Jones TR, Elkins KL. J Immunol; 1996 Dec 01; 157(11):5042-8. PubMed ID: 8943413 [Abstract] [Full Text] [Related]
35. Extrathymic development of self-reactive gamma(delta) T cells in athymic BALB/c nu/nu mice. Matsuzaki G, Kenai H, Fujise S, Kobayashi N, Kishihara K, Nomoto K. Cell Immunol; 1996 Oct 10; 173(1):49-54. PubMed ID: 8871600 [Abstract] [Full Text] [Related]
36. Specificity and longevity of antitumor immune responses induced by B7-transfected tumors. Townsend SE, Su FW, Atherton JM, Allison JP. Cancer Res; 1994 Dec 15; 54(24):6477-83. PubMed ID: 7527298 [Abstract] [Full Text] [Related]
37. Induction of murine gamma delta T cells cytotoxic for xenogeneic rat cells. Okumura C, Suto R, Furukawa K, Ahmed SS, Furukawa K, Nakayama E, Fujii T, Shiku H. J Immunol; 1995 Feb 01; 154(3):1114-23. PubMed ID: 7822788 [Abstract] [Full Text] [Related]
38. Immune protection and control of inflammatory tissue necrosis by gamma delta T cells. Fu YX, Roark CE, Kelly K, Drevets D, Campbell P, O'Brien R, Born W. J Immunol; 1994 Oct 01; 153(7):3101-15. PubMed ID: 8089489 [Abstract] [Full Text] [Related]
39. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. Lanier LL, O'Fallon S, Somoza C, Phillips JH, Linsley PS, Okumura K, Ito D, Azuma M. J Immunol; 1995 Jan 01; 154(1):97-105. PubMed ID: 7527824 [Abstract] [Full Text] [Related]
40. B7-CD28 costimulatory signals control the survival and proliferation of murine and human γδ T cells via IL-2 production. Ribot JC, Debarros A, Mancio-Silva L, Pamplona A, Silva-Santos B. J Immunol; 2012 Aug 01; 189(3):1202-8. PubMed ID: 22732586 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]